Incidence and outcome of BCR‐ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitors

PURPOSE: To assess the incidence of BCR‐ABL kinase domain (KD) mutation detection and its prognostic significance in chronic phase chronic myeloid leukemia (CP‐CML) patients treated with tyrosine kinase inhibitors (TKIs). PATIENTS AND METHODS: We analyzed characteristics and outcome of 253 CP‐CML pa...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Med
Autori principali: Etienne, Gabriel, Dulucq, Stéphanie, Huguet, Françoise, Schmitt, Anna, Lascaux, Axelle, Hayette, Sandrine, Fort, Marie‐Pierre, Sujobert, Pierre, Bijou, Fontanet, Morisset, Stéphane, Tavitian, Suzanne, Bidet, Audrey, Turcq, Beatrice, Robbesyn, Fanny, Chollet, Claudine, Belloc, Francis, Durrieu, Françoise, Mahon, François‐Xavier, Nicolini, Franck E.
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2019
Soggetti:
Clinical Cancer Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6718576/
https://ncbi.nlm.nih.gov/pubmed/31350815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2410
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi